Brief: Intelligent Bio Solutions Plans To Add Fentanyl Testing
16/05/2023 12:31
May 16 (Reuters) - Intelligent Bio Solutions Inc
INBS.O :
* INTELLIGENT BIO SOLUTIONS PLANS TO ADD FENTANYL TESTING AS
IT
FURTHER ENHANCES ITS FINGERPRINT-BASED DRUG SCREENING SOLUTION
Source text for Eikon: ID:nGNXc5FTq4
Further company coverage: INBS.O
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study